Peptide Partners
6 tests · avg lab score 8.1/10
Latest Finnrick test Nov 6, 2025
Research
BPC-157
Body Protection Compound-157, a pentadecapeptide derived from human gastric juice.
Grade
A
Finnrick lab signal
Lowest
$36.50Lowest
Peptide PartnersTrust
86trust
← Back to peptide comparisonB A B
Price comparison
Source: Vendor websitesLast tested Mar 2026Current offers across tracked vendors
Lowest price first, with Finnrick grades in the same row so cost never gets divorced from lab context.
Lab data
What the Finnrick results actually show
We highlight current purity and quantity results without implying every vendor or every batch has been tested equally.
Purity distribution
Peptide Partners · Nov 6, 202599.95%
Peptide Partners · Oct 23, 202597.20%
Paradigm Peptide · Nov 1, 202599.98%
A
Verified Peptides
4 tests · avg lab score 7.2/10
Latest Finnrick test Oct 15, 2025
Paradigm Peptide
5 tests · avg lab score 8.9/10
Latest Finnrick test Nov 1, 2025
Polaris Peptides
12 tests · avg lab score 7.0/10
Latest Finnrick test Oct 30, 2025
Price history
Historical tracking comes next
The current schema gives us a trustworthy live market snapshot. It does not yet store price snapshots over time, so the chart module stays honest about that gap.
Historical pricing
Tracking starts with snapshots
The current schema stores live prices but not historical snapshots yet, so this page shows current market comparison rather than pretending time-series data exists. Once snapshots are recorded, this module can render 30-, 90-, and 180-day trends honestly.
Research context
Editorial context beyond the price table
The goal is to keep market data inside a broader research and safety frame, not let the price table become the whole story.
Guide
BPC-157 explainer
BPC-157 is a synthetic gastric peptide extensively studied in animal models for tissue repair and gut healing. It has no completed human trials and is classified as an FDA Category 2 bulk drug substance.
Read the full research guide →PubMedResearchEditor's pick
BPC-157 Accelerates Tendon Healing in a Rat Achilles Injury Model
A controlled preclinical study found that systemic BPC-157 administration significantly improved biomechanical properties of healing Achilles tendons at 14 and 28 days post-injury. The peptide group showed 37% greater maximum load-to-failure compared to controls.
Mar 23, 2026Mar 23, 2026
BPC-157peptidesrecovery
Science DailyResearch
Researchers Develop Novel Delivery System for Hydrophilic Peptides
A team at MIT has developed a lipid nanoparticle formulation capable of delivering hydrophilic peptides orally with bioavailability exceeding 30%, compared to typical subcutaneous injection efficiency. The platform was demonstrated with BPC-157 analogs in a rodent pharmacokinetic study.
Mar 22, 2026Mar 22, 2026
BPC-157peptidesresearch
Research information only
Peptide Daily is an informational resource only. Peptide research chemicals are not approved for human use by the FDA unless otherwise noted. Nothing on this site constitutes medical advice. Consult a qualified healthcare provider before using any peptide or research chemical.